Healthtech Startups

Alma is a nutrition coach and food tracker app for iOS that allows users to log meals via voice, photo, or text and tracks calories, macros, and 25+ nutrients.

1 investor

Alma Clinics is a digital-native primary healthcare provider offering care through physical clinics, homecare, and telehealth via its app. It uses AI and machine learning to support its services.

1 investor

Alma develops medical aesthetic and healthcare technology platforms including lasers and treatment devices designed to deliver safe and effective treatments for patients. The company serves aesthetic practitioners, clinics, and medical professionals globally.

1 investor

Almond provides obstetric and gynecologic care through both in-person clinics and telehealth, using back-office technology designed to optimize physician schedules and employing a broader team of care providers to reduce patient wait times.

1 investor

Alnu Health offers a patient companion app and clinician platform that supports GLP-1 therapy patients between visits with clinically backed guidance, lifestyle reinforcement, and escalation visibility. It serves weight management clinics and larger healthcare system programs, aiming to improve treatment adherence while reducing administrative burden on care teams.

1 investor

Alo Solutions provides capital investment and practice transition support services for independent physicians seeking to expand their practices, plan for succession, or transition their patient panels. The company offers tailored financing options and operates the Avance Care platform to help physician-owners optimize their practices and plan for sustainable futures.

1 investor

Aloe Therapeutics develops AIM-001, a localized cell-based immunotherapy implanted at a tumor site during biopsy or resection surgery to activate the immune system and make patients more responsive to checkpoint immunotherapy. It targets advanced solid tumors across multiple tumor types and disease stages.

1 investor

Aloe Health matches individuals to health insurance plans based on their doctors, medications, family, and preferences, comparing options across thousands of plans to find the best price. It presents personalized plan recommendations rather than generic group coverage.

1 investor

AlpfaMed develops a Pulsed Field Ablation (PFA) technology that uses targeted, heat-free electrical energy to remodel prostate tissue and treat Benign Prostatic Hyperplasia (BPH). The approach is designed as a tissue-selective, incision-free alternative to conventional surgical and heat-based BPH treatments for men.

1 investor

Alpha Cancer Technologies (ACT) is a biopharmaceutical company developing and commercializing targeted immuno-oncology and immunomodulation therapies. It operates in the cancer therapeutics space.

1 investor

A biopharmaceutical company developing oncology treatments including EGFR-targeting small molecule drugs for lung cancer with CNS penetration, and expanding into cell immunotherapy through licensed partnerships for NK cell and CAR-T therapies targeting solid tumors and hematologic malignancies.

1 investor

ATEC Spine develops surgical devices and approaches for spine surgery, targeting decompression, stabilization, and alignment for surgeons treating spinal pathologies. The company operates in the medical technology sector focused on spine surgery.

1 investor

Alphyn Biologics develops Multi-Target Therapeutics based on its Zabalafin (AB-101) platform to treat skin diseases, with a lead candidate, zabalafin hydrogel, a non-steroidal topical treatment for atopic dermatitis in children and adults that targets itch, inflammation, and Staph bacteria. The company operates in the biotech/dermatology drug development sector and has completed a Phase 2a clinical trial.

1 investor

Alsteni Medical develops an intraoral gastrointestinal access device designed to deliver nutrient therapy for metabolic management. The company is advancing the device through FDA 510(k) clearance with clinical evidence and manufacturing partnerships in place.

1 investor

Alta Partners is a venture capital firm focused on life sciences and healthcare investments, with a portfolio that has generated over 90 FDA-approved products and includes both therapeutic companies and tech-enabled patient care services.

1 investor

Alta Smiles develops the V5x, a smartphone-based imaging device for dental and orthodontic providers to capture high-quality intra and extraoral photos in-office and enable remote patient monitoring during treatment. The system reduces appointment time and improves workflow efficiency for dental practices.

1 investor

Altach Biomedical develops cartilage repair solutions for the orthopedic medical device industry. The company showcases its innovative technologies at major MedTech conferences to engage with investors and strategic partners.

1 investor

Altair Health provides an AI-driven medical billing service for independent medical practices, handling the full billing process and submitting claims to insurers while human billers manage exceptions. It uses a theorem prover that checks each billing action against formalized insurer policies before claims are submitted, and learns insurer payment behavior over time to predict payments, denials, and delays.

1 investor

AlterDiag is a diagnostics company founded by executives with backgrounds in immunology R&D and business strategy. The page focuses on the founding team and does not detail the specific product beyond its work in the diagnostics market.

1 investor

Alter Echo develops technology that keeps personnel outside cleanrooms while reducing disposable gown waste in pharmaceutical manufacturing. The company targets pharmaceutical facilities seeking to improve workplace safety, environmental sustainability, and operational efficiency.

1 investor

AlterG develops anti-gravity treadmill systems using patented Differential Air Pressure technology to enable rehabilitation and athletic training. The systems serve orthopedic rehabilitation, neurological condition management, active aging, and athletic performance improvement.

1 investor

Alteron Therapeutics is a pharmaceutical company focused on drug innovation. The available page does not detail its specific therapeutic areas or products.

1 investor

Altesa BioSciences is a clinical-stage pharmaceutical company developing vapendavir, an orally administered antiviral targeting rhinovirus infections in patients with chronic lung diseases such as COPD and asthma. The drug aims to stop viral infections before they trigger acute respiratory exacerbations, addressing the underlying viral cause rather than downstream inflammation.

1 investor

Althexis offers a subscription-based sales assistant tool that combines skin analysis with product recommendations, along with sponsored product placements and a business analytics platform providing anonymized demographic and behavioral data. It targets pharmacists and healthcare partners in the skincare retail space.

1 investor